Cetera Trust Company’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $327K | Buy |
2,880
+225
| +8% | +$25.6K | 0.2% | 92 |
|
|
2025
Q1 | $279K | Hold |
2,655
| – | – | 0.18% | 109 |
|
|
2024
Q4 | $284K | Buy |
2,655
+75
| +3% | +$8.04K | 0.18% | 99 |
|
|
2024
Q3 | $258K | Buy |
2,580
+25
| +1% | +$2.5K | 0.16% | 131 |
|
|
2024
Q2 | $215K | Buy |
2,555
+75
| +3% | +$6.32K | 0.14% | 144 |
|
|
2024
Q1 | $181K | Buy |
2,480
+275
| +12% | +$20.1K | 0.11% | 176 |
|
|
2023
Q4 | $157K | Buy |
+2,205
| New | +$157K | 0.1% | 174 |
|